Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about With 11 Drugs In Development, Moderna Seeks $600M More From Investors
Venture Capital

With 11 Drugs In Development, Moderna Seeks $600M More From Investors

by bostonglobe.com posted 2years ago 3349 views
Moderna, launched by the local venture capital firm Flagship Ventures, has attracted widespread interest in the biopharma world by pioneering a technology called messenger RNA that can carry protein replacement drugs inside cell membranes, where they can help fight cancers and other genetic disorders.